Debottlenecking Bioprocessing: How Automation and CaptureSMB® Are Transforming Downstream Purification
Biopharmaceutical manufacturers must balance three competing priorities: higher capacity, lower costs, and consistent, high-quality results. As biologics demand increases – particularly for monoclonal antibodies (mAbs) – that balance is becoming harder to maintain. And critical constraints in traditional downstream processing are more and more apparent.
At the center of this pressure is a critical step: protein A capture chromatography.
The Growing Bottleneck in mAb Manufacturing
Advancements in upstream processing have significantly increased cell culture titers. While this is a major achievement, it has also created a new set of downstream challenges. Higher titers mean more product entering purification, and existing capture systems often struggle to keep up.
Protein A chromatography, long considered a robust and reliable step, is now frequently the primary bottleneck in downstream purification. The issue is not just capacity. It’s time, efficiency, and available resources.
Traditional batch processes are limited by:
- Incomplete resin utilization
- Long processing times
- High buffer consumption
- Increased operational complexity
As a result, manufacturers are often forced to choose between scaling up infrastructure or accepting inefficiencies. Neither scenario is ideal.
Rethinking Capture: The Role of SMB Technology
Simulated Moving Bed (SMB) chromatography offers a fundamentally different approach to capture. Instead of relying on a single column operating below its full capacity, SMB systems enable continuous processing and improved resin utilization.
YMC’s approach simplifies this concept even further.
Rather than using complex multi-column systems, YMC’s CaptureSMB technology utilizes just two columns in series. This design allows the second column to capture breakthrough product from the first, enabling continuous loading and significantly increasing efficiency.
The impact is substantial:
- Resin utilization increases from ~60% to over 90%
- Buffer consumption can be reduced by up to 50%
- Product concentration improves
- Overall productivity increases
In practical terms, this means manufacturers can process more product with the same amount of resin in less time, which directly addresses both cost and capacity challenges.
Defining Productivity in Downstream Processing
In downstream purification, productivity is often defined as:
The amount of product processed per unit of resin over a given time.
Improving productivity has a compounding effect:
- Lower cost per gram of product
- Increased facility throughput
- Reduced need for capital investment
CaptureSMB maximizes resin efficiency and dramatically reduces downtime between cycles.
The Criticality of Simplicity: A Two-Column Advantage
Many SMB systems rely on multiple columns, which can introduce operational complexity and validation challenges. YMC’s two-column design offers a distinct advantage.
Fewer columns mean:
- Simplified system design
- Reduced risk of failure points
- Easier validation and regulatory compliance
- Faster implementation
This streamlined approach makes SMB more accessible, particularly for organizations transitioning from traditional batch processes.
Automation is Key | Meet AutomAb®
While SMB provides the structural efficiency, automation is what makes it practical, scalable, and reliable.
Modern bioprocessing requires:
- Precise control
- Reproducibility
- Real-time data generation
- Regulatory-compliant documentation
YMC’s automation platform, AutomAb, is designed to meet these demands by dynamically adapting to process variability in real time.
Adaptive Process Control
In traditional systems, variability in feed concentration can lead to inconsistent performance. Automation addresses this directly.
For example:
- If protein concentration increases, the system detects earlier breakthrough and adjusts accordingly
- If concentration decreases, the system extends loading to maintain optimal performance
This ensures consistent cycle execution, regardless of upstream variability.
Eliminating Manual Decision-Making
Manual intervention introduces variability and risk. Automation removes this dependency by:
- Executing decisions based on real-time data
- Standardizing process control
- Ensuring repeatability across runs
The result is improved consistency and reduced operator burden.
Scaling with Confidence
One of the most significant challenges in bioprocessing is scaling from development to manufacturing.
Automation plays a critical role here by ensuring that:
- Processes developed at the bench scale can be reliably reproduced at large scale
- Minor variations during scale-up are automatically corrected
- Process integrity is maintained throughout
This reduces risk and accelerates time to production.
Operational Benefits Beyond Performance
Beyond yield and productivity gains, automation also transforms day-to-day operations.
Manufacturers benefit from:
- Fewer required samples
- Reduced analytical workload
- Shorter wait times between steps
- Minimal need for manual intervention
- Improved workflow efficiency
These operational improvements translate into faster processing times and more efficient use of personnel and resources.
Supporting the Transition to Continuous Processing
Adopting new technology can be challenging, especially in regulated environments. That’s why successful implementation goes beyond the technology itself.
YMC supports customers through:
- Training programs and workshops
- Guided implementation strategy
- Software tools and process support
- Validation assistance
This structured approach helps organizations transition from traditional batch processing to continuous or semi-continuous workflows with confidence.
A Proven Path Forward
For many manufacturers, the move toward automation and SMB is no longer optional. It’s essential to success.
Pairing CaptureSMB with adaptive control platforms like AutomAb is a powerful step forward for manufacturers – enabling:
- Increased productivity
- Reduced costs
- Simplified operations
- Scaling with confidence
In an industry where efficiency and reliability are paramount, these advancements are not just improvements. They are transformative.
As one of our customers put it:
“This technology helped debottleneck our downstream processing.”
